Medicines Patent Pool (MPP)

Did AbbVie Inc. violate human rights with its pricing for a best-selling medicine? A Dutch court recently agreed to decide the question, which was raised in a lawsuit by a public interest group that

2022 turned out to be a relatively quiet year on the M&A and partnering front in Japan – or at least it was until mid-December, when Takeda Pharmaceutical Co. Ltd. announced it would pay an eye-wate

2022 turned out to be a relatively quiet year on the M&A and partnering front in Japan – or at least it was until mid-December, when Takeda Pharmaceutical Co. Ltd. announced it would pay an eye-wate

Shionogi & Co. Ltd. ’s oral antiviral for COVID-19, Xocova (ensitrelvir), has been approved in Japan on its third attempt and will become the third such drug available in the country, although the fir